Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection

Fangjia Yang,Paula Beltran-Lobo,Katherine Sung,Caoimhe Goldrick,Cara L. Croft,Agnes Nishimura,Erin Hedges,Farah Mahiddine,Claire Troakes,Todd E. Golde,Beatriz G. Perez-Nievas,Diane P. Hanger,Wendy Noble,Maria Jimenez-Sanchez

DOI: https://doi.org/10.1126/sciadv.adk9884

IF: 13.6

2024-03-21

Science Advances

Abstract:Molecular chaperones are protective in neurodegenerative diseases by preventing protein misfolding and aggregation, such as extracellular amyloid plaques and intracellular tau neurofibrillary tangles in Alzheimer's disease (AD). In addition, AD is characterized by an increase in astrocyte reactivity. The chaperone HSPB1 has been proposed as a marker for reactive astrocytes; however, its astrocytic functions in neurodegeneration remain to be elucidated. Here, we identify that HSPB1 is secreted from astrocytes to exert non–cell-autonomous protective functions. We show that in human AD brain, HSPB1 levels increase in astrocytes that cluster around amyloid plaques, as well as in the adjacent extracellular space. Moreover, in conditions that mimic an inflammatory reactive response, astrocytes increase HSPB1 secretion. Concomitantly, astrocytes and neurons can uptake astrocyte-secreted HSPB1, which is accompanied by an attenuation of the inflammatory response in reactive astrocytes and reduced pathological tau inclusions. Our findings highlight a protective mechanism in disease conditions that encompasses the secretion of a chaperone typically regarded as intracellular.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the function of heat shock protein B1 (HSPB1) in reactive astrocytes in Alzheimer's disease (AD) and its mechanism of action for neuroprotection. Specifically, the research focuses on the following points:

1. **Expression pattern of HSPB1 in AD brains**: The researchers found that HSPB1 is mainly expressed in astrocytes and is significantly increased in astrocytes surrounding amyloid plaques and in the extracellular space around them.

2. **Secretion mechanism of HSPB1**: The researchers explored how HSPB1 is secreted from astrocytes, especially whether the secretion of HSPB1 is increased under inflammatory reaction conditions. The results showed that HSPB1 is mainly secreted as a free protein, rather than through extracellular vesicles (EVs).

3. **Intercellular transfer of HSPB1**: The researchers further verified whether HSPB1 can be taken up by surrounding cells (such as astrocytes and neurons) and explored its subcellular localization after uptake. Experiments showed that HSPB1 can be taken up by astrocytes and neurons and is mainly located in lysosomes and late endosomes.

4. **Anti - inflammatory effect of HSPB1**: The researchers evaluated the effect of HSPB1 on reactive astrocytes in response to exogenous inflammatory stimuli. The results showed that exogenous HSPB1 can significantly reduce the inflammatory response of astrocytes and the secretion of pro - inflammatory factors.

5. **Protective effect of HSPB1 in disease models**: The researchers used a mouse brain slice culture model to observe the protective effect of human - derived HSPB1 expressed by virus on neurodegenerative pathological changes. The results showed that HSPB1 can reduce the neurotoxicity caused by inflammatory factors and the accumulation of pathological inclusions in the P301L/S320F mutant tau model.

In summary, this paper aims to reveal the specific mechanism by which HSPB1 exerts a neuroprotective effect in AD in a non - cell - autonomous manner (that is, secreted from astrocytes into the extracellular space and then taken up by other cells), providing a theoretical basis for the development of new treatment strategies.